Benign Prostate Hyperplasia (BPH) Treatment Market: Top Companies, Industry Size & Share to 2028- TechSci Research

Spread the love

Introduction to Benign Prostate Hyperplasia (BPH) Treatment Market

The Benign Prostate Hyperplasia (BPH) Treatment Market has been a focal point of medical research and industry analysis due to its substantial impact on the aging male population. According to the comprehensive report by TechSci Research, titled “Benign Prostate Hyperplasia (BPH) Treatment Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” this market is slated to experience a notable Compound Annual Growth Rate (CAGR) from 2023 to 2028. This growth is primarily attributed to the rising incidence of hormonal imbalances and the expanding aging demographic worldwide.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Global Benign Prostate Hyperplasia (BPH) Treatment Market” – https://www.techsciresearch.com/report/benign-prostate-hyperplasia-bph-treatment-market/14694.html

Understanding BPH and Treatment Approaches

Benign Prostate Hyperplasia is characterized by the non-cancerous enlargement of the prostate gland, leading to the compression of the urethra and subsequent urinary complications. The condition causes the bladder wall to thicken and weaken, hindering its ability to release urine efficiently. While the term “benign” suggests non-malignancy, risk factors such as aging and family medical history elevate the likelihood of BPH development in men.

Market Dynamics Impacting Growth

Despite the optimistic growth forecast, several factors might impede the market’s progress in the forthcoming years. Stringent regulatory frameworks and insufficient awareness about urological conditions could potentially decelerate market expansion. Moreover, the scarcity of proficient medical practitioners capable of performing minimally invasive BPH treatment procedures, particularly in emerging economies, may further hinder market growth.

Segmentation of the Global BPH Treatment Market

Drug Treatment Segment

The market segmentation for BPH treatment encompasses drug-based interventions such as alpha blockers, 5-alpha reductase inhibitors, and phosphodiesterase-5 inhibitors. Notably, the segment involving phosphodiesterase-5 inhibitors is poised for substantial growth during the forecast period due to its demonstrated efficacy in addressing BPH symptoms.

Surgical Treatment Segment

Various surgical techniques play a pivotal role in addressing BPH. These techniques include transurethral resection of the prostate (TURP), prostatic urethral lift (PUL), prostatectomy, laser surgery, transurethral microwave technique (TUMT), transurethral needle ablation of the prostate (TUNA), among others. Among these, the TURP segment is projected to dominate the market until 2028, primarily owing to the escalating demand for minimally invasive procedures and supportive government healthcare policies.

End-User Segmentation

The BPH treatment market can also be segmented by end-users, including hospitals & clinics, ambulatory surgical centers, and other healthcare facilities. Hospitals and clinics currently hold the dominant share and are anticipated to maintain their prominence in the coming years. This dominance is fueled by advancements in healthcare infrastructure and governmental initiatives aimed at bolstering treatment accessibility. The convenience factor associated with hospitals compared to ambulatory surgical centers also contributes significantly to market growth.

Who Will Benefit from This Report?

Medical Practitioners and Researchers

Medical professionals involved in urology, pharmaceuticals, and healthcare research can leverage this report’s insights to understand emerging trends, treatment efficacy, and market dynamics related to BPH.

Healthcare Administrators and Policy Makers

Hospital administrators and policymakers can utilize this comprehensive analysis to formulate strategies for enhancing healthcare infrastructure, improving patient access to BPH treatments, and implementing effective regulatory measures.

Pharmaceutical Companies and Investors

Pharmaceutical firms and investors seeking opportunities within the BPH treatment market can benefit from the forecasted trends, competitive landscape, and potential areas for investment highlighted in this report.

In conclusion, the projected growth of the Global BPH Treatment Market offers significant opportunities for various stakeholders, provided that challenges related to regulations, awareness, and healthcare infrastructure are effectively addressed. This report serves as a comprehensive guide, enabling informed decision-making and strategic planning in the dynamic landscape of BPH treatment.

The leading companies operating in the Global BPH Treatment Market are:

Boston Scientific Corporation
Coloplast Corporation
Teleflex Incorporated
Olympus Corporation
Glaxo Smith Kline PLC
Eli Lily
Abbott Laboratories
Medifocus Inc.
Urologix, LLC
Pfizer Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The prevalence of the BPH is rising, which is encouraging the use of cutting-edge therapies including laser therapy, prostatic stenting, and UroLift therapy and propelling the growth of the sector in the area. The advancement of the players in the region over the coming few years will also be supported by attractive reimbursement rules and an increase in the number of qualified surgeons. There are a number of device and pharmaceutical businesses in the area, and they are all keenly interested in undertaking R&D operations and developing new products to improve the standard of care. Furthermore, laser therapy is widely used due to the availability of cutting-edge medical infrastructure. Modern laser equipment is available in many clinics and urology centres to treat BPH, which advances the area.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“BPH Treatment Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitors, and phosphodiesterase-5 inhibitors), By Surgical Treatment (Transurethral resection of the prostate (TURP), Prostatic Urethral Lift (PUL), Prostatectomy, Laser Surgery, Transurethral Microwave Technique (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), and Others), By End User (Hospitals & Clinics, , Ambulatory Surgical Centers, and Others), By Region,” has evaluated the future growth potential of Global BPH Treatment Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global BPH Treatment Market.

Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=14694

Recently Published Report –

Benign Prostate Hyperplasia (BPH) Treatment Market

Bioidentical Hormones Market

India Natural Food Ingredients Market

Linkedin — https://www.linkedin.com/pulse/benign-prostate-hyperplasia-bph-treatment-0igvc/

Contact Techsci Research-

US –

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017